SeaStar Medical Holding ROE 2021-2024 | ICU
SeaStar Medical Holding ROE - Return on Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Shareholder's Equity | Return on Equity |
2024-12-31 | $-0.02B | $0.00B | 640.00% |
2024-09-30 | $-0.03B | $0.00B | 429.63% |
2024-06-30 | $-0.03B | $-0.01B | 312.20% |
2024-03-31 | $-0.03B | $0.00B | 275.56% |
2023-12-31 | $-0.03B | $-0.01B | 192.31% |
2023-09-30 | $-0.02B | $-0.02B | 162.71% |
2023-06-30 | $-0.02B | $-0.01B | 146.15% |
2023-03-31 | $-0.02B | $-0.01B | 150.00% |
2022-12-31 | $-0.01B | $-0.02B | 109.09% |
2022-09-30 | $-0.01B | $-0.01B | 138.46% |
2022-06-30 | $-0.01B | $-0.01B | 100.00% |
2022-03-31 | $-0.01B | $-0.01B | 200.00% |
2021-12-31 | $-0.01B | $0.00B | 1000.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.013B | $0.000B |
SeaStar Medical Holding Corporation is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. SeaStar Medical Holding Corporation, formerly known as LMF Acquisition Opportunities Inc., is based in Denver, Colorado. |